(Q34342581)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23639322%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Cytokine patterns in patients with cancer: a systematic review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23639322%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23639322%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Bodo E Lippitz

series ordinal

1

1 reference

1 August 2017

publication date

1 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23639322%20AND%20SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23639322%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23639322%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23639322%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

e218-28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23639322%20AND%20SRC:MED&resulttype=core&format=json

Immunity, Inflammation, and Cancer

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Serological identification of human tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Cancer-related inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Inhibiting the inhibitors: evaluating agents targeting cancer immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Effector-phase tolerance: another mechanism of how cancer escapes antitumor immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Immunosuppressive networks in the tumour environment and their therapeutic relevance

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Interferons, immunity and cancer immunoediting

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

The immunobiology of cancer immunosurveillance and immunoediting

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Cancer and inflammation: an old intuition with rapidly evolving new concepts

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Smad3 is essential for TGF-beta 1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Beta transforming growth factors are potential regulators of B lymphopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

The role of TGF-beta in growth, differentiation, and maturation of B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Transforming growth factor-beta : biology and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Transforming growth factor-beta and the immune response to malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

CXCL12 (SDF-1)/CXCR4 pathway in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

New insights on the role of CXCR4 in cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Organ selectivity in metastasis: regulation by chemokines and their receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Stable Overexpression of Smad7 in Human Melanoma Cells Impairs Bone Metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Transforming growth factor-beta1 upregulates the expression of CXC chemokine receptor 4 (CXCR4) in human breast cancer MCF-7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Interleukin-10 and the immune response against cancer: a counterpoint

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Interleukin-10: new perspectives on an old cytokine

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Mast cell homeostasis: a fundamental aspect of allergic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Recruitment of STAT3 for production of IL-10 by colon carcinoma cells induced by macrophage-derived IL-6.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Interleukin-6 induces the generation of IL-10-producing Tr1 cells and suppresses autoimmune tissue inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Interleukin-6 leads to interleukin-10 production in several human multiple myeloma cell lines. Does interleukin-10 enhance the proliferation of these cells?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

IL-2, regulatory T cells, and tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Interleukin-12 and the regulation of innate resistance and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Regulation of tumor growth by IFN-gamma in cancer immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

CD8+ T Cell Effector Mechanisms in Resistance to Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

The production of IFN-gamma by IL-12/IL-18-activated macrophages requires STAT4 signaling and is inhibited by IL-4.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Synergistic effects of IL-4 and IL-18 on IL-12-dependent IFN-gamma production by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Cytokines as communication signals between leukocytes and endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Signaling in innate immunity and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Cardiac dysfunction in severe sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Tumour necrosis factor and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Tumor necrosis factor-alpha promotes malignant pleural effusion

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Macrophage migration inhibitory factor and host innate immune responses to microbes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Inflammation and cancer: macrophage migration inhibitory factor (MIF)--the potential missing link

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Macrophage migration inhibitory factor: a regulator of innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

How much is too much? Interleukin-6 and its signalling in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Effects of IL6 on B cells in mucosal immune response and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

T helper1/t helper2 cells and resistance/susceptibility to leishmania infection: is this paradigm still relevant?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

How regulatory T cells work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

T-regulatory cells: key players in tumor immune escape and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

1 reference

7 January 2021

Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

IL-23: one cytokine in control of autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

The role of macrophage- and dendritic cell-derived IL12 in Th1 phenotype development

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Transforming growth factor-beta induces development of the T(H)17 lineage

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

IL-23 promotes tumour incidence and growth

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Antibody targeting of TGF-β in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

The antisense oligonucleotide trabedersen (AP 12009) for the targeted inhibition of TGF-β2.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Exploring anti-TGF-β therapies in cancer and fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Tumor Necrosis Factor α As a New Target for Renal Cell Carcinoma: Two Sequential Phase II Trials of Infliximab at Standard and High Dose

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Tumor microenvironments direct the recruitment and expansion of human Th17 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Role of tumor-associated macrophages in tumor progression and invasion

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970582-X

7 January 2021

10.1016/S1470-2045(12)70582-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23639322%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference